Skip to main content

Table 1 Clinical characteristics in 153 esophageal squamous cell carcinoma patients

From: The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy

Variables

Categories

No. of patients (%)

Gender

Male

128 (83.66)

Female

25 (16.34)

Age

Year

61.93 ± 6.72

Tobacco

Yes

66 (43.14)

No

87 (56.86)

Alcohol

Yes

57 (37.25)

No

96 (62.75)

Hypertension

Yes

13 (8.50)

No

140 (91.50)

Diabetes

Yes

2 (1.31)

No

151 (98.69)

Tumor stage

0–II

79 (51.63)

III

74 (48.37)

Depth of invasion

T1–T2

38 (24.84)

T3

115 (75.16)

Lymph node

N0

79 (51.63)

N1–N3

74 (48.37)

Differentiation

Well-moderate

123 (80.39)

Poor

30 (19.61)

Tumor size (cm)

≤ 4

109 (71.24)

> 4

44 (28.76)

Radio-chemotherapy

Yes

92 (60.13)

No

61 (39.87)

NLR

 

2.88 (0.16–14.40)

dNLR

 

3.52 (0.01–24.07)

PLR

 

137.47 (8.38–673.68)

LMR

 

5.17 (1.03–65.40)

Fib

mg/dL

3.29 (1.8–5.42)

Alb

g/L

40.4 (22.8–49.8)

AFR

 

12.13 (5.74–22.15)

ADS

Low

87 (56.86)

High

66 (43.14)

  1. NLR neutrophil to lymphocytes ratio, dNLR derived neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, LMR lymphocyte to monocyte ratio, Fib fibrinogen, Alb albumin, AFR albumin to fibrinogen ratio, ADS AFR–Alb–dNLR score